Chengxiang Dai

1.7k total citations · 3 hit papers
22 papers, 1.3k citations indexed

About

Chengxiang Dai is a scholar working on Molecular Biology, Genetics and Rheumatology. According to data from OpenAlex, Chengxiang Dai has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Rheumatology. Recurrent topics in Chengxiang Dai's work include Extracellular vesicles in disease (8 papers), Mesenchymal stem cell research (8 papers) and Osteoarthritis Treatment and Mechanisms (7 papers). Chengxiang Dai is often cited by papers focused on Extracellular vesicles in disease (8 papers), Mesenchymal stem cell research (8 papers) and Osteoarthritis Treatment and Mechanisms (7 papers). Chengxiang Dai collaborates with scholars based in China, United States and France. Chengxiang Dai's co-authors include Suke Li, Liangjing Lu, Yang Song, Hui Du, Li Zhang, David J. Hunter, Li Zhang, Xiaoling Gao, Jieming Qu and Mengmeng Shi and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

Chengxiang Dai

22 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial

2019 184 citations Liangjing Lu, Chengxiang Dai et al. Stem Cell Research & Therapy profile →
Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study

2022 131 citations Yinggang Zhu, Mengmeng Shi et al. Stem Cell Research & Therapy profile →
Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial

2023 89 citations Xinyi Xie, Qingxiang Song et al. General Psychiatry profile →

Peers

Countries citing papers authored by Chengxiang Dai

Since Specialization

Citations

This map shows the geographic impact of Chengxiang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengxiang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengxiang Dai more than expected).

Fields of papers citing papers by Chengxiang Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengxiang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengxiang Dai. The network helps show where Chengxiang Dai may publish in the future.

Co-authorship network of co-authors of Chengxiang Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Chengxiang Dai. A scholar is included among the top collaborators of Chengxiang Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengxiang Dai. Chengxiang Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Manufacturing, quality control, and GLP-grade preclinical study of nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles 2024 ·Stem Cell Research & Therapy ·Jing Wang, (unknown), (unknown), Meiping Shen, Bo Zhao, Wei Zhang, Ye Zhang, (unknown), (unknown), Jing Chang, (unknown), Meng Li, (unknown), (unknown), Chengxiang Dai, (unknown), (unknown)	6
2	Three-dimensional texture analyses of multi-quantitative relaxation time maps for evaluating cartilage repair with the treatment of allogeneic human adipose-derived mesenchymal progenitor cells 2024 ·Magnetic Resonance Imaging ·(unknown), (unknown), Jia Li, Chengxiang Dai, Mengchao Pei, Yan Zhou	2
3	Bioorthogonal microglia-inspired mesenchymal stem cell bioengineering system creates livable niches for enhancing ischemic stroke recovery via the hormesis 2023 ·Acta Pharmaceutica Sinica B ·Jianpei Xu, (unknown), Yang You, Yuwen Zhang, Dan Huang, Songlei Zhou, Yipu Liu, (unknown), Fenfen Ma, Qingxiang Song, Chengxiang Dai, Suke Li, (unknown), Zhihua Wang, Xiaoling Gao, Jun Chen	3
4	Comparative Proteomics Inspired Self‐Stimulated Release Hydrogel Reinforces the Therapeutic Effects of MSC‐EVs on Alzheimer's Disease 2023 ·Advanced Materials ·Meng Huang, Mengna Zheng, Qingxiang Song, Xinyi Ma, Qian Zhang, Huan Chen, Gan Jiang, Songlei Zhou, Hongzhuan Chen, Gang Wang, Chengxiang Dai, Suke Li, Ping Li, Hao Wang, Ao Zhang, Yukun Huang, Jun Chen, Xiaoling Gao	33
5	Surface-tethered ROS-responsive micelle backpacks for boosting mesenchymal stem cell vitality and modulating inflammation in ischemic stroke treatment 2023 ·Journal of Controlled Release ·Yang You, Yipu Liu, (unknown), Jianpei Xu, (unknown), (unknown), (unknown), Fenfen Ma, Yukun Huang, Junbin Liu, (unknown), Chengxiang Dai, Suke Li, (unknown), Qiyong Mei, Xiaoling Gao, Jun Chen	26
6	Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial breakdown → 2023 ·General Psychiatry ·Xinyi Xie, Qingxiang Song, Chengxiang Dai, Shishuang Cui, Ran Tang, Suke Li, Jing Chang, Ping Li, Jin‐Tao Wang, Jianping Li, Chao Gao, Hongzhuan Chen, Shengdi Chen, Ru‐Jing Ren, Xiaoling Gao, Gang Wang	89
7	Tailored Apoptotic Vesicle Delivery Platform for Inflammatory Regulation and Tissue Repair to Ameliorate Ischemic Stroke 2023 ·ACS Nano ·Yang You, Jianpei Xu, Yipu Liu, Haichun Li, (unknown), (unknown), (unknown), (unknown), Kaifan Liang, Songlei Zhou, Fenfen Ma, Qingxiang Song, (unknown), (unknown), Chengxiang Dai, Suke Li, (unknown), Qiyong Mei, Xiaoling Gao, Jun Chen	49
8	Clinical application of a double-modified sulfated bacterial cellulose scaffold material loaded with FGFR2-modified adipose-derived stem cells in urethral reconstruction 2022 ·Stem Cell Research & Therapy ·(unknown), Jiayu Yang, (unknown), Zicheng Wang, Chengxiang Dai, Suke Li, Xuesong Li, Yajie Xie, Yudong Zheng, Jian Lin, Liqun Zhou	13
9	Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study breakdown → 2022 ·Stem Cell Research & Therapy ·Yinggang Zhu, Mengmeng Shi, Antoine Monsel, Chengxiang Dai, Xuan Dong, Hong Shen, (unknown), Jing Chang, (unknown), Ping Li, Jing Wang, Meiping Shen, (unknown), Dechang Chen, Jieming Qu	131
10	Repair of Large-Scale Rib Defects Based on Steel-Reinforced Concrete-Designed Biomimetic 3D-Printed Scaffolds with Bone-Mineralized Microenvironments 2022 ·ACS Applied Materials & Interfaces ·Baoshuai Bai, (unknown), (unknown), Tao Wang, Xiaodi Wu, (unknown), Yiyang Wang, Chengxiang Dai, Yujie Hua, (unknown), Guangdong Zhou	10
11	Large-sized bone defect repair by combining a decalcified bone matrix framework and bone regeneration units based on photo-crosslinkable osteogenic microgels 2021 ·Bioactive Materials ·(unknown), Baoshuai Bai, Zheng Ci, Jincheng Tang, (unknown), Chengxiang Dai, Mengyuan Yu, Meng Li, Wei Zhang, Yixin Zhang, Wenjie Ren, Yujie Hua, Guangdong Zhou	81
12	Preclinical efficacy and clinical safety of clinical‐grade nebulized allogenic adipose mesenchymal stromal cells‐derived extracellular vesicles 2021 ·Journal of Extracellular Vesicles ·Mengmeng Shi, Qingyuan Yang, Antoine Monsel, Jiayang Yan, Chengxiang Dai, Jingya Zhao, Guochao Shi, Min Zhou, (unknown), (unknown), Ping Li, Jing Wang, Meng Li, (unknown), (unknown), Yinggang Zhu, Jieming Qu	153
13	Human adipose, placenta, and umbilical cord-derived mesenchymal stem cells ameliorate imiquimod-induced psoriatic mice via reducing T cells infiltration 2021 ·Biocell ·(unknown), Zhenyao Xu, Suke Li, Meng Li, Zhikai Wang, Ping Li, Jing Wang, (unknown), (unknown), (unknown), (unknown), Chengxiang Dai	3
14	ADSCs-derived extracellular vesicles alleviate neuronal damage, promote neurogenesis and rescue memory loss in mice with Alzheimer's disease 2020 ·Journal of Controlled Release ·Xinyi Ma, (unknown), Mengna Zheng, Chengxiang Dai, Qingxiang Song, Qian Zhang, Qian Li, Xiao Gu, Huan Chen, Gan Jiang, Ye Yu, Xuesong Liu, Suke Li, Gang Wang, Hongzhuan Chen, Liangjing Lu, Xiaoling Gao	121
15	Intra-Articular Injections of Allogeneic Human Adipose-Derived Mesenchymal Progenitor Cells in Patients with Symptomatic Bilateral Knee Osteoarthritis: A Phase I pilot study 2020 ·Regenerative Medicine ·Liangjing Lu, Chengxiang Dai, Hui Du, Suke Li, Ping Ye, Li Zhang, Xiaoying Wang, Yang Song, (unknown), C. Thomas Vangsness, Chunde Bao	34
16	Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial breakdown → 2019 ·Stem Cell Research & Therapy ·Liangjing Lu, Chengxiang Dai, Zhongwen Zhang, Hui Du, Suke Li, Ping Ye, Qiong Fu, Li Zhang, Xiaojing Wu, Yuru Dong, Yang Song, Dongbao Zhao, Yafei Pang, Chunde Bao	184
17	Multi-compositional MRI evaluation of repair cartilage in knee osteoarthritis with treatment of allogeneic human adipose-derived mesenchymal progenitor cells 2019 ·Stem Cell Research & Therapy ·(unknown), (unknown), Hui Tang, Jia Li, (unknown), Meng Li, Suke Li, (unknown), Qing Lü, Chengxiang Dai	51
18	Human Adipose-Derived Mesenchymal Stem Cells for Osteoarthritis: A Pilot Study with Long-Term Follow-Up and Repeated Injections 2018 ·Regenerative Medicine ·Yang Song, Hui Du, Chengxiang Dai, Li Zhang, Suke Li, David J. Hunter, Liangjing Lu, (unknown)	190
19	Target cell killing effects of CD20 targeting chimeric antigen receptor T cells derived from the type II anti-CD20 antibody. 2017 ·Journal of Clinical Oncology ·Yihong Yao, Xin Yao, (unknown), Wei Zhu, (unknown), Qingxia Wang, Lin Zhu, (unknown), Yanfeng Li, Yutian Wei, Chengxiang Dai, Zhang Li, Jiaqi Huang, (unknown)	2
20	Human Adipose-Derived Mesenchymal Progenitor Cells Engraft into Rabbit Articular Cartilage 2015 ·International Journal of Molecular Sciences ·Wen Wang, Na He, Chenchen Feng, Victor Liu, Luyi Zhang, Fei Wang, Jiaping He, (unknown), Shuyang Wang, (unknown), Suke Li, Guangdong Zhou, Li Zhang, Chengxiang Dai, Wei Cao	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact